Maximize Your Business Prospects in the Rapidly-Expanding RNA-Targeting Small Molecules Space
With the RNA-targeting small molecules field reaching a pivotal point, pharmaceutical companies such as AbbVie, Biogen, and Novartis are racing to become first-in-class. In order to achieve this, they require support in preclinical safety and efficacy studies, screening tools for RNA target discovery, in vivo models, and more.
This industry-focused conference is your premium opportunity to meet and network with 200+ discovery, target validation, preclinical, and translational experts from the likes of Pfizer, Daiichi Sankyo, Anima Bio, NextRNA Therapeutics, EPICS Therapeutics and more. Make long-lasting connections with potential customers within the RNA-small molecules community and maximize the opportunity to generate revenue for your business
If you offer relevant services and want to maximize your company’s exposure, contact us today to discuss your bespoke commercial package.
The field of small molecules targeting RNA is maturing, and biotech companies around the world are racing to become first-in-class. To achieve this, they need support in assays, screening, sequencing, AI, discovery, preclinical, and more.
Experts need your help with:
Screening Tools & Platforms for RNA Structures
Artificial Intelligence & Machine Learning
Preclinical CROs for Safety & Efficacy
In Vivo Models for RNA-Targeting Small Molecules
Benefit from Market Intelligence in RNA-Targeting Small Molecules Drug Development
Refresh your client list and discover companies within the RNA-targeting small molecules space, such as AbbVie, Novartis, Ananke Therapeutics, and Expansion Therapeutics to generate new business leads
Meet & Network with Industry Pioneers from the Likes of Pfizer, Biogen & Arrakis Therapeutics
Secure invaluable face-to-face time with key decision makers wanting to progress their small molecule drugs from early discovery to preclinical stages through structured networking
Raise Brand Awareness Within the Community
Increase market share through unique branding formats such as exhibition booths, lead partnership options, or a dedicated presentation to show how your screening techniques can help progress biopharma and academia’s RNA-small molecule drug discovery
Generate Commercial Collaborations
Make sure your hottest prospects are in the room and part of the discussion by having a wish list of your choice contacted in advance of the event and ensure that you are set up for success in securing significant contacts for desired commercial gain